Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SML | Ann: Interim Financial Report | 12/03/19 | 0 | 77 | |||
|
|||||||
SML | Ann: Units on Issue Disclosure - February 2019 | 06/03/19 | 0 | 94 | |||
|
|||||||
SML | Ann: Quarterly Portfolio Disclosure | 28/02/19 | 0 | 62 | |||
|
|||||||
SML | Ann: Units on Issue Disclosure - January 2019 | 06/02/19 | 0 | 51 | |||
|
|||||||
SML | Ann: Estimated Distribution Component Information - December 2018 | 11/01/19 | 0 | 94 | |||
|
|||||||
SML | Ann: Units on Issue Disclosure - December 2018 | 07/01/19 | 0 | 79 | |||
|
|||||||
SML | Ann: DRP Issue Price | 02/01/19 | 0 | 185 | |||
|
|||||||
SML | Ann: Final Distribution Announcement | 02/01/19 | 0 | 328 | |||
|
See All Discussions